Followers | 5 |
Posts | 108 |
Boards Moderated | 0 |
Alias Born | 09/25/2014 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly, they need to get the presses going if you know what I mean. We already got a taste of what a small minuscule press release does to the share price. Bertner Advisors need to get on the ball, plain and simple.
Titan needs to stay on track with no derails — milestones need to get met. This will attract more investors or a possible M&A.
Regardless I'm a buyer. I don't want to be on the other side of the fence when that explosive news hits the presses.
It's imperative that Titan stays inline with their forecasted timeline. We have already seen the aftermath with they don't hit their trajectory goals.
$TITXF We have to question Bertner's involvement — what are they bringing to the table?
https://twitter.com/JeezTrades
I believe in $TITXF, Fowler and the team are top notch, but they could use some help in the PR department.
$TITXF as mentioned yesterday, it needed a news catalyst to move the price. The "OTCQX Best 50" press release moved the stock, but "investinthefuture" put this out yesterday on IH, he beat Titan to the punch.
Now we need some earth shattering news, something explosive. I'm sure Titan has some press releases up their sleeve.
https://twitter.com/JeezTrades
"A surgeon can only perform as well as she can see
Imaging technology and minimally invasive procedures are dependent on one another. Dr. Dennis Fowler, director of clinical and regulatory affairs at Titan Medical Inc, recalled a time before that was the case. "The first 10 years I did surgery we made bigger incisions in order to see better," said Fowler.
Despite the myriad benefits of imaging technology, Fowler said those breakthroughs deprived surgeons of a lot of sensory feedback. They could no longer feel things or perceive depth. The technology literally came between the surgeon and the patient. "Everything that's happened since 1990 has been to restore sensory input to the surgeon and every iteration of better imaging brings us closer," said Fowler. " http://www.dotmed.com/news/story/24345?p_begin=0
https://twitter.com/JeezTrades
Yes, the possibilities are really high. Check my previous post on IH:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107019316
Dr. Fowler is like Michael Jordan when it comes to laparoscopic surgical procedures, and Sony is like Nike, the best in basketball shoe retail, and what you get is a match made in heaven! Back up the truck on $TITX. I rarely promote pink stocks, but Titan has a ton of potential.
https://twitter.com/JeezTrades
You're a good man Longmoney. $TITXF needs a news catalyst to move the share price — otherwise, it will continue to drip like it has. Either way, I'm looking to go long again. Just looking for the right spot to jump in, kind of like double-dutch jump rope!
The key item we all have to consider and question is Bertner Advisors and their whopping retainer fee of $20,000 per month "for its services." This marriage with Bertner Advisors has not yielded great returns, they seem dormant.
On the other hand, there's a clause about an additional fee increase in the event that a merger, or acquisition occurs. This is our "gold vein" when it happens.
https://twitter.com/JeezTrades
Longmoney's Quote:
"If you were looking at a large piece of real estate and knowing that it had a massive vein of gold running through it"
LOL!! Who are you? Are you Jack and the Beanstalk? Be realistic, next thing you'll say is the realtor that wants to sell you the house with the gold massive vein, has nipples that are 24K gold plated!!
Longmoney, I wouldn't worry about the share price, what worries me is when they don't hit their goal milestones, and have to adjust their future timeline. I can control my end, but I can't control their end.
Here's an analogy for you lonemoney. If you were at a swap meet, and saw a cool beach cruiser would you pay top dollar for the bike knowing it had some noticeable dings on it? Or would you negotiate a better price with the seller? Would you buy at Market or at Limit? Understand where I'm going with this. You gotta be aggressive to win big, but doing efficiently and consistently.
Did buy and hold, but I sold for a profit when $TITXF adjusted their goal milestone timeline. That's when the stock started to drip slowly. Since then, it has been looking for a bottom. I want to buy again, bigger this time, so I can hold again. I expect for them not to change their timeline.
$TITXF Dr. Fowler, management, directors, and the surgeon advisory board are top notch in the industry. These folks wouldn't associate their names if they didn't believe in this groundbreaking technology. Plain and simple.
Mr. Longmoney, First off, I have never shorted TITXF. Second, I have bought TITXF, and have sold it at various price levels. Now, TITXF is looking attractive — if it drops to $1 I will back up the truck. Nothing wrong with that? I agree, TITXF is a buy out candidate. I've been saying this since the beginning.
Keeping an eye on TITXF, sitting at a key support level. Waiting for a break, if this hits $1 — I'm a buyer. Fowler has a top notch group behind him, no company can measure to Titan's experience.
TITXF will most likely get acquired once they hit key milestones/FDA approvals.
1.26 is a key area. It bounced off it this morning.
In the recent past, it has touched this 1.26 price on the day's low on several occasions — so it'll be interesting to see if it holds.
Looking to break the day high. Key break area is 1.70
I wouldn't worry about that BAW185 dude, he's a runt.
The stock got shorted as some of you know — that's part of the game. Shorters capitalized on the delay news, which drove it straight down with the panic, but eventually they had to cover their shorts.
Tim Sykes shorted 32000 at 1.6616. It was just a matter of time when the stock would pull back from the "buy to covers". The stock was oversold.
http://profit.ly/1MpqPR
Anyways, money to be made on both ends. That call to buy in the 1.20's was dead on — check my previous post.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108289483
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108183177
It's time to lick your wounds and move on. The MMs accomplished their goal, it did what it wanted you to do…sell for a loss!
The drop is clearly a short raid, the shorters capitalized on the delay news. Plain and simple. Stock can't really drop any further, since its holding the 1.24–1.26 area. And from a technical standpoint, the stock is oversold, definitely not a short candidate here at this level — the drive down has already been exhausted.
Bertner Advisors just needs to start to extend their "investor reach" and begin to build awareness on Wall Street, as they claim to say. And for a retainer fee of US $20,000 per month, they need to start running "press machines", and get the word out on TITXF.
At Friday's low again at 1.26, but not before breaking the 1.00 dollar mark, and bouncing back. It'll be interesting to see if this holds, the stock has been heavily shorted as of late, but the damage has been done. The stock has already capitulated.
Just like I said before, it's like flushing out the diarrhea.
Thanks for posting that. Great TA.
I mentioned in a previous post that the 1.26 low on Friday was a key support area — it bounced off that, and still holding on the top range... but if it breaks to the downside, we'll hit the low .80's.
Additionally, to hit the 1.26 mark today is something it needed to do, I big "flush out" — MMs at their best.
As i call it, flushing out the shit. It sort of like having diarrhea, and now that TITXF has done it's load of crap, it can move forward and up.
Just waiting on that "catalyst"
The morning dip presented a good buying opportunity. Shorts are going to get squeezed in a bit — I'd like for it to break the 1.70 mark before the close today.
Well put Mr. Sandman. Titan is the real deal!
Titan has a medical advisory board of leading surgeons as well as partnerships with academic institutions and hospitals around the globe.
Top 4 NASDAQ Stocks In The Real Estate Development Industry With The Highest Gross Margin
Below are the top real estate development stocks on the NASDAQ in terms of gross margin.
The trailing-twelve-month gross margin at China HGS Real Estate (NASDAQ: HGSH) is 33.10%. China HGS Real Estate's EPS for the same period is $0.71.
The trailing-twelve-month gross margin at LGI Homes (NASDAQ: LGIH) is 25.30%. LGI Homes' PEG ratio is 0.89.
The trailing-twelve-month gross margin at Stratus Properties (NASDAQ: STRS) is 19.50%. Stratus Properties' ROA for the same period is 0.60%.
The trailing-twelve-month gross margin at China Housing and Land Development (NASDAQ: CHLN) is 15.00%. China Housing and Land Development's revenue for the same period is $147.00 million.
Look at the bid size from ETRF, it's at 30,300 @ 2.00. ATDF is that level too, but much lower shares.
Take note of the last 10 minutes of volume traded. (over 100k)
They were mainly gobbling up the bids, which why it was held down.
Thanks for the expiration dates honeycomb!
You gotta love these MMs…
60,000 on the bid side (2.00). Major support.
I'd like to know when they expire, since they are dilutive.
That's what I was figuring too.
Their valuation is set to dramatically increase with each milestone they meet — just can't wait for the commercialization in Europe!
NEW YORK, Oct. 13, 2014 (GLOBE NEWSWIRE) -- ITG Market Research today released the results of a new global survey of hospital executives in the US, France, Germany, the UK, Japan, and Korea that highlights positive trends as well as looming challenges facing the global hospital industry.
Quote:
"Additional topics in the new ITG Market Research report include brand-level purchasing for robotic surgery equipment, large capital equipment, and a variety of cardiovascular, orthopaedic, and spine implants. The report also introduces ITG's Global Hospital Executive Confidence Index, tracks deployment of supply chain management strategies such as vendor consolidation and market-share discounting, and also provides insight into how current trends are affecting executives' investment and purchasing plans."
See more at:
http://globenewswire.com/news-release/2014/10/13/672557/10102219/en/Hospital-Executives-in-US-and-Europe-Expect-Investment-and-Spending-to-Increase-as-Economies-Improve.html
Just an FYI…
Some of you know this:
MAKO Surgical, was snapped up last year by Stryker Corporation for about $1.65 billion, giving you an idea of how deep Intuitive is.
Thanks Honeycomb.
These plays come by rarely, and when you have the odds on your side, you gotta invest aggressively and sometimes "bet the farm".
Just can't wait util Titan and their development partner, Ximedica, receive FDA permission to market the SPORT surgical system, and couple that with the approval of a CE Mark from the European Union, add the design freeze, U.S. uplist, and this stock is sure to take off and never come down.
And as you know, they have continued to meet their milestones and remain on track for commercialization in 2015.
It looks like Dr. Fowler has had a long standing working relationship with sony's grant program for years now.
https://pro.sony.com/bbsccms/assets/files/mkt/med/articles/generalSurgeryNews.pdf
The Doctor Is In At Sony
By CHUCK ANSBACHER, AV NETWORK on October 08, 2014 8:30 am
Yesterday I saw the most impressive 3D video I’ve ever seen in my life. I wasn’t in an IMAX theater.
I wasn’t watching Gravity. And fortunately, I wasn’t eating popcorn.
At an event Thursday night, Sony hosted a small selection of the press at its New York headquarters ostensibly to unveil a new 27-inch high definition medical monitor.
While the monitor is big news for Sony and the medical community—it’s incredibly slim, flawlessly designed, and is the brightest surgical monitor ever released—the event was about much more than that. Sony took us on a journey through its extensive suite of healthcare offerings, including cameras, recorders, and printers, and did a great job of illustrating how deeply embedded these products are in all areas of the medical industry.
The highlight of the event, however, wasn’t a product.
Sony hosted a panel of four nationally recognized physicians, Richard Mackool, MD, Dennis Fowler, MD, Steve Palter, MD, and Daniel Eun, MD. (These guys are all MDs, btw.) Each took turns describing in depth the incredible difference that advancements in AV have made to their practices, professions, and students.
These testimonials were eye-opening to say the least. All of them couldn’t say enough about the huge role AV and Sony have played in advancing medicine, especially surgery.
And this is where the 3D video came in.
One of the greatest advancements, they all attested, was the ability to watch live surgery, and show students and fellow doctors video of medical procedures, in 3D.
For example, Dr. Mackool, assistant director of the Mackool Eye Institute and Laser Center, showed a video of a cataract operation in 3D. The precision necessary to perform this standard operation—we’re talking down to the millimeter—is almost impossible to convey in two dimensions. Of course, such operations were done well before 3D video existed, but with 3D technology, he was convinced he could teach his grade school age kids how to perform cataract surgery in a matter of weeks.
The same went for Dr. Eun, associate professor of urology and director of minimally invasive robotic urologic oncology and reconstructive surgery at Temple University School of Medicine. He showed 3D video of a kidney tumor operation, which, hands down, was the craziest 3D I’ve ever seen. It was unbelievable, and I can only imagine a completely indispensable learning tool.
Sony has been on the front lines with these doctors, often working hand in hand to bring the highest resolutions and most advanced AV into operating rooms and medical schools. The endorsements given by these doctors were very compelling, and spoke to the ambitious ways in which Sony is pushing the envelope in this field.
http://www.c2meworld.com/distributiondelivery/the-doctor-is-in-at-sony/
"Sony hosted a panel of four nationally recognized physicians, Richard Mackool, MD, Dennis Fowler, MD, Steve Palter, MD, and Daniel Eun, MD. (These guys are all MDs, btw.) Each took turns describing in depth the incredible difference that advancements in AV have made to their practices, professions, and students. "
I'm licking my chops right now — things are getting exciting.
Found an interesting article!
Sony unveils new full HD LCD 27 inch surgical monitor
October 07, 2014
by Gus Iversen , Staff Reporter
On Thursday evening, Sony hosted a press conference to unveil a sleek new surgical monitor. The event took place at the Sony Club on the top floor of Sony's New York headquarters, and included an overview of the monitor's specs, a performance demonstration, and insights from a panel of minimally invasive surgeons on the significance of better visualization technology in the operating room.
The monitor's 27 inch viewing area makes it slightly larger than most monitors on the market, but it is compact enough to fit the same chassis footprint as most 26 inch monitors, so many facilities will be able to use them on their current carts or boom arms. The monitor can also be ceiling mounted and is built for ease of use, featuring a thin bezel and minimalist design. A surgical procedure played on loop throughout the conference and, while the footage was not for the faint of heart, the image quality was undeniably exceptional.
Although Sony has 29 years experience in the medical industry, Julie Holodak, senior manager of product marketing, opened the event by acknowledging that most people associate them with entertainment. After listing off several new, big budget movies utilizing Sony equipment, she said Sony has an initiative to take their technology "from the movie theater to the surgical theater." As one of their panelists later explained, that is a time-honored approach to innovation.
Dr. Steven Palter, Founder and Director of Gold Coast IVF said, "If you look at the history of surgery since 1900, all innovations came from entertainment technology." The first films were recorded by the Lumiere brothers and a couple years later, said Palter, the same cameras were used to film the surgeries of Dr. Eugène-Louis Doyen. "In the 1930's they made Gone with the Wind in color and then came color surgical videos."
A surgeon can only perform as well as she can see
Imaging technology and minimally invasive procedures are dependent on one another. Dr. Dennis Fowler, director of clinical and regulatory affairs at Titan Medical Inc, recalled a time before that was the case. "The first 10 years I did surgery we made bigger incisions in order to see better," said Fowler.
Despite the myriad benefits of imaging technology, Fowler said those breakthroughs deprived surgeons of a lot of sensory feedback. They could no longer feel things or perceive depth. The technology literally came between the surgeon and the patient. "Everything that's happened since 1990 has been to restore sensory input to the surgeon and every iteration of better imaging brings us closer," said Fowler.
The display panel on Sony's new monitor features a brightness of 1000 cd/m2 (maximum brightness of 800 cd/m2 at D65 adjustment), which Sony said makes it the brightest monitor on the surgical market. It comes in two versions: the LMD-2760MD (digital only interface) and the LMD-2765MD (digital and analog interface for compatibility with a range of HD and SD imaging sources).
The monitor has other features that add to the image quality too, including an advanced Sony technology called A.I.M.E. which reduces noise and improves visibility. A.I.M.E. offers four contrast modes and eight color modes to get the best visualization of the tissue being operated on. The monitor also utilizes OptiContrast to minimize reflection and glare.
Dr. Richard Mackool, assistant director of the Mackool Eye Institute and Laser Center, said the teaching capability of Sony's new monitor outperforms anything he has seen before. "It's been a pleasure to work with this device," said Mackool, "The more I work with it the more I can teach other people."
Sony's new monitor will become available for purchase this November, with price yet to be announced.
http://www.dotmed.com/news/story/24345?p_begin=0
Agreed, big money to be made down the road, the stock is clearly undervalued considering all the near term catalyst. (design freeze, uplist, patent approvals, contracts…etc.)
From a technical standpoint, the past few months the stock has found support/resistance at this 2.10–2.20 range. Nice consolidation.